Share on twitter
This story is part of a WKMS News series highlighting organizations and groups helping others amid the pandemic.
The COVID-19 pandemic affected lives all over the world in many different ways, but one of the most pressing and troubling outcomes is the rising reports of child abuse, domestic abuse and sexual abuse. Kentucky’s abuse crisis centers not only adapted their services to comply with recommended health and safety guidelines, but also adjusted their approach to reach victims during a time when leaving an abusive situation could be harder than ever.
United Nations Women, an organization of the UN, calls it “the Shadow Pandemic.” According to their website, one in three women experienced violence before COVID-19 changed the world, but the virus brings in stressors that experts believe make abuse worse and more frequent. The UN said cramped living conditions, worries over finances, deserted public spaces, and isolation with the abuser are just some of th
4:12
United Nations Women, an organization of the UN, calls it “the Shadow Pandemic.” According to their website, one in three women experienced violence before COVID-19 changed the world, but the virus brings in stressors that experts believe make abuse worse and more frequent. The UN said cramped living conditions, worries over finances, deserted public spaces, and isolation with the abuser are just some of the ways the pandemic could exacerbate abuse.
In Kentucky, abuse crisis centers serve entire regions of the state. They usually offer a hybrid of resources for multiple types of abuse: domestic, sexual and child abuse. They also work together in a network of “sister organizations.”
To embed, copy and paste the code into your website or blog:
Under President Joe Biden, pharmaceutical regulation may see increased FDA guidance, new strategies to speed up innovation and regulatory review, and a renewed focus on diseases with unmet needs, among other expectations.
With President Joe Biden sworn in as the 46th US president, attention has turned to what actions he will take in his first 100 days in office, and beyond. While much of the president’s focus will initially be on the COVID-19 pandemic, increasing vaccination numbers, and economic relief, the pharmaceutical and biotechnology industries, which have been at the forefront of the executive branch’s attention since the start of COVID-19, will likely continue to garner significant policy focus. Specifically, over the next four years, we expect to see more Food and Drug Administration (FDA) independence, transparency, and funding; the application of new strategies to facilitate pharmaceutical product developm
MedCity News
Rebuild clinical trials in the image of patient need. Join Sanofi, Janssen, FDA, Pfizer and more
Clinical 2021 is US and EU pharma’s leading event for clinical innovators - join 500+ executive attendees from across the globe to meet and learn virtually.
Shares0
Clinical is under the microscope. As the world focuses its lens on pharma, the opportunity and the pressure are there to establish a new era of agile, patient-centric clinical trials. Long standing barriers to innovation are being swiftly dismantled, digital transformation is accelerating, and a culture of novel collaboration, agility and patient centricity is growing.
Reuters Events’ Clinical 2021 (April 7-9) is the new home of clinical collaboration, innovation and discovery. Join hundreds of pharma clinical innovators plus leaders from across the business, such as real-world evidence, medical, and patient centricity, alongside key regulatory bodies, providers, and patient representatives to form new